XML 15 R5.htm IDEA: XBRL DOCUMENT v3.20.2
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (Unaudited) - USD ($)
Preferred Stock [Member]
Common Stock [Member]
Additional Paid-In Capital [Member]
Accumulated Deficit [Member]
Accumulated Other Comprehensive Loss [Member]
Non-Controlling Interest [Member]
Total
Balance at Dec. 31, 2018 $ 126 $ 101 $ 77,647,544 $ (55,721,115) $ (3,902,523) $ 40,658 $ 18,064,791
Balance (in shares) at Dec. 31, 2018 126,434 100,910          
Increase (Decrease) in Stockholders' Equity              
Stock based compensation: Options     493,954       493,954
Stock based compensation: Common stock   $ 9 253,010       253,019
Stock based compensation: Common Stock (Shares)   9,375          
Issuance of common stock for cash   $ 192 5,453,552       5,453,744
Issuance of common stock for cash (in shares)   191,179          
Issuance of common stock in payment of accrued liabilities   $ 9 108,514       108,523
Issuance of common stock in payment of accrued liabilities (in shares)   9,375          
Issuance of common stockupon exercise of warrants   $ 700 6,620,325       6,621,025
Issuance of common stock upon exercise of warrants (in shares)   699,887          
Issuance of Series A preferred stock for cash $ 6   140,144       140,150
Issuance of Series A preferred stock for cash (in shares) 5,606            
Issuance of common stock for conversion of debt   $ 26 2,608,431       2,608,457
Issuance of common stock for conversion of debt (in shares)   26,402          
Beneficial conversion feature in connection with convertible notes     188,448       188,448
Fair value warrants issued in connection with convertible notes     58,448       58,448
Cash for exchange fees and other financing costs     (1,195,005)       (1,195,005)
Comprehensive loss:              
Net loss       (10,737,507)     (10,737,507)
Preferred dividends       (7,153)     (7,153)
Net unrealized loss on derivatives in related party         (361,181)   (361,181)
Foreign currency translation adjustments         192,505   192,505
Net loss attributable to non-controlling interest           (32,416) (32,416)
Balance at Jun. 30, 2019 $ 132 $ 1,037 92,377,365 (66,465,775) (4,071,199) 8,242 21,849,802
Balance (in shares) at Jun. 30, 2019 132,040 1,037,128          
Balance at Mar. 31, 2019 $ 126 $ 231 84,903,648 (62,401,594) (4,478,216) 8,242 18,032,437
Balance (in shares) at Mar. 31, 2019 126,504 231,478          
Increase (Decrease) in Stockholders' Equity              
Stock based compensation: Options     248,340       248,340
Issuance of common stock for cash   $ 97 1,056,112       1,056,209
Issuance of common stock for cash (in shares)   96,388          
Issuance of common stock in payment of accrued liabilities   $ 9 108,514       108,523
Issuance of common stock in payment of accrued liabilities (in shares)   9,375          
Issuance of common stockupon exercise of warrants   $ 700 6,620,325       6,621,025
Issuance of common stock upon exercise of warrants (in shares)   699,887          
Issuance of Series A preferred stock for cash $ 6   138,394       138,400
Issuance of Series A preferred stock for cash (in shares) 5,536            
Beneficial conversion feature in connection with convertible notes     188,448       188,448
Fair value warrants issued in connection with convertible notes     58,448       58,448
Cash for exchange fees and other financing costs     (944,864)       (944,864)
Comprehensive loss:              
Net loss       (4,058,897)     (4,058,897)
Preferred dividends       (5,284)     (5,284)
Net unrealized loss on derivatives in related party         375,499   375,499
Foreign currency translation adjustments         31,518   31,518
Balance at Jun. 30, 2019 $ 132 $ 1,037 92,377,365 (66,465,775) (4,071,199) 8,242 21,849,802
Balance (in shares) at Jun. 30, 2019 132,040 1,037,128          
Balance at Dec. 31, 2019 $ 132 $ 3,318 101,099,347 (88,650,465) (5,511,624) 8,242 6,948,950
Balance (in shares) at Dec. 31, 2019 132,040 3,318,390          
Increase (Decrease) in Stockholders' Equity              
Stock based compensation: Options     40,134       40,134
Stock based compensation: Common stock   $ 65 73,385       73,450
Stock based compensation: Common Stock (Shares)   65,000          
Issuance of common stock in payment of short term advances, related party   $ 661 739,287       739,948
Issuance of common stock in payment of short term advances, related party (in shares)   660,667          
Issuance of common stock in payment of accrued liabilities   $ 153 228,548       228,701
Issuance of common stock in payment of accrued liabilities (in shares)   153,124          
Issuance of common stock for conversion of debt   $ 1,915 2,686,711       2,688,626
Issuance of common stock for conversion of debt (in shares)   1,914,936          
Beneficial conversion feature in connection with convertible notes     66,582       66,582
Fair value warrants issued in connection with convertible notes     691,508       691,508
Comprehensive loss:              
Net loss       (7,907,081)     (7,907,081)
Preferred dividends       (7,394)     (7,394)
Net unrealized loss on derivatives in related party         (481,213)   (481,213)
Foreign currency translation adjustments         (51,407)   (51,407)
Balance at Jun. 30, 2020 $ 132 $ 6,112 105,625,502 (96,564,940) (6,044,244) 8,242 3,030,804
Balance (in shares) at Jun. 30, 2020 132,040 6,112,117          
Balance at Mar. 31, 2020 $ 132 $ 5,402 104,558,973 (95,186,473) (6,902,325) 8,242 2,483,951
Balance (in shares) at Mar. 31, 2020 132,040 5,401,721          
Increase (Decrease) in Stockholders' Equity              
Stock based compensation: Options     20,178       20,178
Issuance of common stock in payment of accrued liabilities   $ 140 155,407       155,547
Issuance of common stock in payment of accrued liabilities (in shares)   140,624          
Issuance of common stock for conversion of debt   $ 570 568,094       568,664
Issuance of common stock for conversion of debt (in shares)   569,772          
Beneficial conversion feature in connection with convertible notes     46,237       46,237
Fair value warrants issued in connection with convertible notes     276,613       276,613
Comprehensive loss:              
Net loss       (1,375,533)     (1,375,533)
Preferred dividends       (2,934)     (2,934)
Net unrealized loss on derivatives in related party         760,881   760,881
Foreign currency translation adjustments         97,200   97,200
Balance at Jun. 30, 2020 $ 132 $ 6,112 $ 105,625,502 $ (96,564,940) $ (6,044,244) $ 8,242 $ 3,030,804
Balance (in shares) at Jun. 30, 2020 132,040 6,112,117